Zhijian Liu

Title: Zhijian Liu: Innovator in Anti-Infective Agents

Introduction

Zhijian Liu is a prominent inventor based in Kendall Park, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-infective agents. With a total of six patents to his name, Liu's work has the potential to impact the treatment of bacterial infections.

Latest Patents

Liu's latest patents include innovative methods for preparing hydroxylamine derivatives that are useful in the preparation of anti-infective agents. One of his notable inventions relates to processes for the preparation of N-protected 4-((2S,5R)-5-((benzyloxy)amino)piperidine-2-carboxamido)piperidine-1-carboxylates. These compounds are essential in the development of beta-lactamase inhibitors, specifically targeting compounds like (2S,5R)-7-oxo-N-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide. Another significant patent involves processes for preparing beta-lactamase inhibitor hydroxylurea intermediates, which also contribute to the creation of effective anti-infective agents.

Career Highlights

Throughout his career, Zhijian Liu has worked with notable companies such as Merck Sharp & Dohme Corporation and Cardiome International AG. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Liu has collaborated with esteemed colleagues, including Nobuyoshi Yasuda and John Limanto. These partnerships have fostered an environment of innovation and have led to the successful development of various pharmaceutical solutions.

Conclusion

Zhijian Liu's contributions to the field of anti-infective agents through his patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.